AstraZeneca PLC
4 December 2001
DEALING BY DIRECTORS
COMPANIES ACT 1985 SECTIONS 324/329
ASTRAZENECA PLC ANNOUNCES THAT, ON 3 DECEMBER 2001, MR J R SYMONDS, A DIRECTOR
OF THE COMPANY, ACQUIRED 272 OF THE COMPANY'S USD0.25 ORDINARY SHARES AT A
PRICE OF 2146P FOLLOWING THE EXERCISE OF AN OPTION UNDER THE COMPANY'S SAVINGS
RELATED SHARE OPTION SCHEME. MR SYMONDS' INTEREST IN THE ORDINARY SHARES OF
THE COMPANY HAS INCREASED TO 14,314 SHARES WHICH REPRESENTS LESS THAN 0.001
PER CENT OF THE NUMBER OF SHARES IN ISSUE. MR SYMONDS NOW HAS OPTIONS OVER
130,561 ORDINARY SHARES.
G H R MUSKER
COMPANY SECRETARY
4 DECEMBER 2001
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.